Tewari, K. S., Sill, M. W., Coleman, R. L., Aghajanian, C., Mannel, R., DiSilvestro, P. A., . . . Monk, B. J. (2020). BEVACZIUMAB PLUS FOSBRETABULIN IN RECURRENT OVARIAN CANCER: OVERALL SURVIVAL AND EXPLORATORY ANALYSES OF A RANDOMIZED PHASE II NRG ONCOLOGY/GYNECOLOGIC ONCOLOGY GROUP STUDY. Gynecol Oncol.
Stile di citazione ChicagoTewari, Krishnansu S., et al. "BEVACZIUMAB PLUS FOSBRETABULIN IN RECURRENT OVARIAN CANCER: OVERALL SURVIVAL AND EXPLORATORY ANALYSES OF A RANDOMIZED PHASE II NRG ONCOLOGY/GYNECOLOGIC ONCOLOGY GROUP STUDY." Gynecol Oncol 2020.
Citazione MLATewari, Krishnansu S., et al. "BEVACZIUMAB PLUS FOSBRETABULIN IN RECURRENT OVARIAN CANCER: OVERALL SURVIVAL AND EXPLORATORY ANALYSES OF A RANDOMIZED PHASE II NRG ONCOLOGY/GYNECOLOGIC ONCOLOGY GROUP STUDY." Gynecol Oncol 2020.